Driven by Innovation & Growth

Our mission is to promote innovation and growth through strengthened networks; advocacy; capital investment; talent attraction, development and retention; and advancing the next generation of leaders.

About Us

Virginia's Life Science Community By the Numbers

  • 3,433 Companies

    Life science companies in Virginia.

  • $8B Industry

    Life Science contributes $8B to Virginia's economy.

  • 30, 504 People

    Employed by Life Science companies in Virginia.

  • $107,281 Average Wage

    Average earnings of life science workers in Virginia.

  • 1,197 Clinical trials

    Biopharmaceutical industry-sponsored trials in Virginia per year.

News

08/01/2025

Roanoke College, Virginia Western Community College to support region as biotech corridor

Roanoke College and Virginia Western Community College are joining together to begin a new biotechnology bachelor’s degree program, according to officials. The program is expected to begin this fall. Officials say the development of the four-year program is a direct response to the region’s need for a strategic workforce that can help elevate the Roanoke

07/28/2025

BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV

RIVANNA®, developers of imaging-based medical technologies, announced that it received $9.92 million in federal funding of a contractual option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). With the execution, this option funding will

07/22/2025

ReAlta Life Sciences Publishes Data Demonstrating RLS-0071 (pegtarazimod) Reduces Brain Inflammation in Preclinical Hypoxic Ischemic Encephalopathy Model

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced the publication of an article in the American Journal of Perinatology showing the ability of RLS-0071 (pegtarazimod) to reduce key measures of brain inflammation in